Description

Lanreotide Acetate is a synthetic octapeptide analog of somatostatin, formulated as the acetate salt for enhanced stability and pharmaceutical processing. This compound is a critical active pharmaceutical ingredient (API) valued for its potent and long-acting inhibitory effects on the secretion of growth hormone and various other peptides. It is primarily required by pharmaceutical manufacturers and research institutions developing treatments for endocrine disorders, including acromegaly and neuroendocrine tumors. Our supply ensures the high purity and consistency essential for advanced therapeutic formulations.

Application

• Pharmaceutical API: Core active ingredient in long-acting injectable depot formulations for the treatment of acromegaly and symptoms of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
• Clinical Research: Utilized in preclinical and clinical studies investigating new therapeutic applications for somatostatin receptor-targeted therapies.
• Drug Delivery System Development: Serves as a model peptide in the research and development of sustained-release and implantable drug delivery technologies.
• Reference Standard: Used as a high-purity chemical reference standard in analytical laboratories for quality control and method validation.
• Peptide Chemistry Research: A subject of interest in academic and industrial research focused on peptide synthesis, modification, and structure-activity relationships.

Basic Information

Item	Details
Product Name	Lanreotide Acetate
CAS No.	127984-74-1
Molecular Formula	C54H69N11O10S2 • xC2H4O2
Molecular Weight	1096.3 g/mol (base, anhydrous free acid)
Synonyms	Lanreotide; BIM-23014; Somatuline; Lanreotide Acetate Salt; D-β-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (cyclic 2-7 disulfide) Acetate; Somatostatin Octapeptide Analog; (2-7)-Disulfide Lanreotide Acetate
EINECS	Contact for details

Quality Control

Our Lanreotide Acetate is manufactured under strict quality management systems. Each batch is subjected to comprehensive analytical testing, including HPLC for purity, peptide content determination, and tests for related substances and residual solvents, to ensure compliance with pharmaceutical-grade standards. Certificates of Analysis (COA) detailing all specifications and test results are provided to guarantee traceability and batch-to-batch consistency for your regulatory submissions and production needs.

Storage

Preserve in a tightly closed container, protected from light. Store at a controlled room temperature or as specified on the label. Due to its hygroscopic (moisture-sensitive) nature, the container must be kept in a dry environment. For long-term storage, consider conditions of 2-8°C.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (MS)	Conforms
Assay (HPLC)	≥ 98.0% (on anhydrous basis)
Peptide Content	≥ 80.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Acetic Acid Content	4.0% - 12.0%
Water Content (KF)	≤ 8.0%
Residual Solvents (GC)	Meets ICH guidelines
Bacterial Endotoxins	< 10.0 EU/mg

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.